Evidence map›Paper›PMID 36281582›Full record

ReviewClinical and experimental dental research2022

Antibacterial effects of natural compounds on biofilm formation of Streptococcus mutans.

Farideh Kamarehei, Mohsen Mehdiabadi, Fariba Naderi

Open access · goldAbstract readReview
In one paragraph

Review in Clinical and experimental dental research, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
3.6field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 23 citations in OpenAlex.

  1. Review
  2. Inhibition of the Biofilm Formation of PlantPharmaceuticals (Basel, Switzerland) · 2024
    Review
  3. Article
  4. Article
  5. Article
  6. Newly designed nanoparticle-drug delivery systems againstInternational journal of clinical and experimental pathology · 2024
    Review
  7. The Antibacterial Properties of Polish Honey againstAntibiotics (Basel, Switzerland) · 2023
    Article
  8. Article
  9. Article
  10. Review
  11. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Farideh KamareheiDepartment of Microbiology, Faculty of Medicine, Hamadan University of Medical Sciences, Hamadan, Iran.ORCID 0000-0001-8717-6997
Mohsen MehdiabadiDepartment of Pediatric Dentistry, Faculty of Dentistry, Hamadan University of Medical Sciences, Hamadan, Iran.
Fariba NaderiDepartment of Pediatric Dentistry, Faculty of Dentistry, Hamadan University of Medical Sciences, Hamadan, Iran.
Hamedan University of Medical Sciences · IR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Streptococcus mutans is the main cariogenic pathogen in the oral cavity, considered to contribute toward oral diseases. S. mutans is predominantly entrapped in plaque biofilms.

objectivesIn this study, we surveyed the antibacterial activity of natural compounds in terms of the biofilm production of S. mutans. MATERIAL AND

methodsWe extracted the studies related to natural compounds affected on S. mutans biofilm from different databases.

resultsDisruption of S. mutans viability in biofilms by a potent new pharmacological factor could inhibit and remove cavities. Various antibacterial agents are needed to destroy biofilms that remove both pathogens and commensal bacteria, and also exert inhibitory effects on many bacterial species.

conclusionsAn effective therapeutic agent for dental caries has to be capable of removing pathogens and their biofilms. Specific virulence attributes of S. mutans exist; hence, natural compounds that have excellent properties to combat such pathogens need to be selected.

Indexed as

Dental CariesDental PlaqueAnti-Bacterial AgentsBiofilmsHumansStreptococcus mutansAnti-Bacterial Agentsantibacterial agentsbiofilmsdental cariesStreptococcus mutans

Identifiers

PMID36281582
PMCPMC9760147
OpenAlexW4307228506

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.